Literature DB >> 305613

Cytotoxic T cells in the lungs of mice infected with an influenza A virus.

K L Yap, G L Ada.   

Abstract

Cytotoxic T cells are present in the lungs and the bronchoalveolar washings of mice infected intravenously (i.v.) or intranasally (i.n.) with live influenza A/WSN virus. After i.v. injection, cytotoxic T cell activity in both spleens and lungs reaches a peak at 6 days when the level of infectious virus recovered from the lungs falls sharply and the mice do not die. If a lethal dose of virus is given intranasally, very high levels of virus appear rapidly in the lungs, and the development of lung consolidation follows slightly behind the appearance of cytotoxic T cells there. When a non-lethal dose of virus is given intranasally, lower levels of virus are found in the lung and the appearance of cytotoxic T cells is delayed. These results suggest that the cytotoxic T cells play a protective role if the level of virus in the lungs does not reach very high levels. After injection of antithymocyte serum, the subsequent level of cytotoxic T cell activity in the lungs was greatly reduced, suggesting that the T cells recovered in lungs had at an earlier stage been circulating cells. However, splenectomized mice develop high levels of cytotoxic T cell activity, after intranasal infection of mice, indicating that the spleen did not contribute substantially to the T cells recovered in the lungs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 305613     DOI: 10.1111/j.1365-3083.1978.tb00428.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  40 in total

Review 1.  Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease.

Authors:  A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection.

Authors:  B S Bender; M P Johnson; P A Small
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

3.  Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors.

Authors:  Hulin Wu; Arun Kumar; Hongyu Miao; Jeanne Holden-Wiltse; Timothy R Mosmann; Alexandra M Livingstone; Gabrielle T Belz; Alan S Perelson; Martin S Zand; David J Topham
Journal:  J Immunol       Date:  2011-09-23       Impact factor: 5.422

4.  Splenic priming of virus-specific CD8 T cells following influenza virus infection.

Authors:  Damian L Turner; Kara L Bickham; Donna L Farber; Leo Lefrançois
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

5.  Cellular changes in lungs of mice infected with influenza virus: characterization of the cytotoxic responses.

Authors:  P R Wyde; T R Cate
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

6.  Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Authors:  Alison J Johnson; Chin-Fun Chu; Gregg N Milligan
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

7.  Synthesis of an HIV-1 Tat transduction domain-rotavirus enterotoxin fusion protein in transgenic potato.

Authors:  T-G Kim; W H R Langridge
Journal:  Plant Cell Rep       Date:  2003-10-10       Impact factor: 4.570

8.  Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol.

Authors:  A Rudent; F Michel; C Labarre; A M Quero; R Zalisz; P Smets
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

9.  The human cytotoxic T cell response to influenza A vaccination.

Authors:  A J McMichael; F Gotch; P Cullen; B Askonas; R G Webster
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

10.  Histopathological changes in the lungs of influenza-infected mice superinfected with Staphylococcus aureus.

Authors:  I D Gardner; T M Kung
Journal:  Br J Exp Pathol       Date:  1980-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.